These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1248 related items for PubMed ID: 15603861

  • 1. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA, Garfield DH, Khan MM, Look RM, Boehm KA, Asmar L.
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [Abstract] [Full Text] [Related]

  • 2. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.
    Hensing TA, Peterman AH, Schell MJ, Lee JH, Socinski MA.
    Cancer; 2003 Aug 15; 98(4):779-88. PubMed ID: 12910523
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.
    Okamoto I, Moriyama E, Fujii S, Kishi H, Nomura M, Goto E, Kiyofuji C, Imamura F, Mori T, Matsumoto M.
    Jpn J Clin Oncol; 2005 Apr 15; 35(4):188-94. PubMed ID: 15845567
    [Abstract] [Full Text] [Related]

  • 4. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
    Glorieux P, Ortmanns P, Marien S, Degives R, Degraeve D, Potvin M, Grauwels D, Schallier D.
    Anticancer Res; 2001 Apr 15; 21(2B):1487-94. PubMed ID: 11396237
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
    Charoentum C, Thongprasert S, Chewasakulyong B.
    Gan To Kagaku Ryoho; 2007 Oct 15; 34(10):1603-7. PubMed ID: 17940374
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD, Burris HA, Morrissey LH, Thomas M, Erland JB, Butts JA, Joseph G, Kalman L, Greco FA.
    Cancer J; 2000 Oct 15; 6(3):151-6. PubMed ID: 10882330
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

  • 8. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
    Socinski MA, Schell MJ, Bakri K, Peterman A, Lee JH, Unger P, Yates S, Hudgens S, Kies MS.
    Cancer; 2002 Sep 15; 95(6):1265-73. PubMed ID: 12216094
    [Abstract] [Full Text] [Related]

  • 9. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A.
    Lung Cancer; 2007 Nov 15; 58(2):238-45. PubMed ID: 17658655
    [Abstract] [Full Text] [Related]

  • 10. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
    Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA.
    Clin Cancer Res; 1997 Jul 15; 3(7):1117-23. PubMed ID: 9815791
    [Abstract] [Full Text] [Related]

  • 11. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A, Yamasaki M, Matsuura K, Kajihara T, Nitta T, Awaya H, Arita K, Kashiwado K, Ohashi N.
    Gan To Kagaku Ryoho; 2009 Oct 15; 36(10):1653-6. PubMed ID: 19838022
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
    Johnson DH, Paul DM, Hande KR, DeVore R.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):42-6. PubMed ID: 9007120
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R.
    Semin Oncol; 1995 Jun 15; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [Abstract] [Full Text] [Related]

  • 14. Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
    Ramalingam S, Perry MC, La Rocca RV, Rinaldi D, Gable PS, Tester WJ, Belani CP.
    Cancer; 2008 Aug 01; 113(3):542-6. PubMed ID: 18512224
    [Abstract] [Full Text] [Related]

  • 15. A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study.
    Natale RB.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):34-7. PubMed ID: 8643968
    [Abstract] [Full Text] [Related]

  • 16. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J, Pang QS, Wang P, Wang J, Wang W.
    Zhonghua Zhong Liu Za Zhi; 2007 Oct 01; 29(10):769-72. PubMed ID: 18396691
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy.
    Yoh K, Kubota K, Kakinuma R, Ohmatsu H, Goto K, Niho S, Saijo N, Nishiwaki Y.
    Lung Cancer; 2007 Oct 01; 58(1):73-9. PubMed ID: 17548127
    [Abstract] [Full Text] [Related]

  • 18. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
    Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, Sherman CA, Rosen DM, Hollis D, Ratain MJ, Green MR.
    Cancer; 2003 May 15; 97(10):2480-6. PubMed ID: 12733147
    [Abstract] [Full Text] [Related]

  • 19. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial.
    Ichiki M, Kawasaki M, Takayama K, Ninomiya K, Kuba M, Iwami F, Miyazaki N, Oishi K, Takeo S, Aizawa H, Nakanishi Y.
    Cancer Chemother Pharmacol; 2006 Sep 15; 58(3):368-73. PubMed ID: 16395589
    [Abstract] [Full Text] [Related]

  • 20. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
    Belani CP, Ramalingam S, Perry MC, LaRocca RV, Rinaldi D, Gable PS, Tester WJ.
    J Clin Oncol; 2008 Jan 20; 26(3):468-73. PubMed ID: 18202422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.